×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Looking Closer into the Utility of Adaptive Approaches
Session Chair(s)
Sue-Jane Wang, PhD, MA, MS
Mathematician Statistician
FDA, United States
Optimal Choice of the Type I Error Rate in Drug Development
Learning Objective : Describe the randomization procedure; Discuss popular adaptive dose designs; Explain statistical principles in drug development.
Speaker(s)
Optimal Choice of the Type I Error Rate in Drug Development
Raina Duan, PhD
Aptiv Solutions, United States
Gaining Information under Ethical/Cost Constraints in Dose Finding Studies
Valerii Fedorov, DrSc
Quintiles Transnational Corp, United States
Vice President, Predictive Analytics, Innovation
A Hybrid Randomization Algorithm Offering the Best of Minimization, Dynamic and Permuted Block Randomization Methods
Jonathan (Yoni) D Lebowitsch
Medidata Solutions Worldwide, United States
Product Manager
Have an account?